Content area

|
|

Mulighed for ændring af ordinationsmønster

Forfatter(e)
Overlæge Lene Ørskov Reuther, overlæge Hanne Rolighed Christensen & farmaceut Camilla Mikkelsen Bispebjerg Hospital, Klinisk Farmakologisk Enhed, og Rigshospitalet, Region Hovedstadens Apotek
Reference: 
Ugeskr Læger 2009;171(37):2655-2656
Blad nummer: 
Sidetal: 
2655-2656
Summary Changing clinicians' prescription patterns Ugeskr Læger 2009;171(37):2655-2656 In 2005 the Central Drug Committee in co-operation with the hospitals in the county of Copenhagen (H:S) focused on the increasing use of and expenditure derived from three tumour necrosis factor alpha (TNF-alpha) inhibitors. While the three inhibitors are estimated to be equivalent regarding efficacy and safety, eternacept and adalimumab are twice as expensive as infliximab. With a little effort, the Central Drug Committee succeeded in changing clinicians' prescription pattern in a cost-effective manner.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Pedram Kazemi-Esfarjani | 28/11
2 kommentarer
af David McWhan | 27/11
4 kommentarer
af Ulf Bern Jensen | 24/11
2 kommentarer
af Bodil Marie Nielsen | 24/11
2 kommentarer
af Jan Nielsen | 23/11
1 Kommentar
af Toke Seierøe Barfod | 23/11
2 kommentarer
af Thorkild I.A. Sørensen | 20/11
1 Kommentar
af Kim Varming | 20/11
1 Kommentar
af Niels Holmark Andersen | 20/11
1 Kommentar